Accellta offers a range of revolutionary solutions for better affordability and quality of stem cell culturing. Accellta's technologies are the result of over 15 years of pioneering research and development at the Stem Cell Center in the Technion’s Rappaport Faculty of Medicine.
Maxells - The Power of Suspension Culturing
Maxells, Accellta’s novel solution for industrialization of embryonic and induced pluripotent stem cell culturing, is based on dynamic culturing of stem cells in suspension without microcarriers. Maxells allows uniform cell growth and improved cell differentiation and delivers unprecedented scalability and quality. Maxells enables cost-effective mass production of stem cells for therapeutic purposes, banking and R&D applications.
Singles - Superior Uniformity and Optimal Scalability
"Singles" is a breakthrough technology that offers a simple and effective way to culture pluripotent stem cells as single-cells in suspension, serving as a platform for genetic manipulation of the cells and providing enhanced uniformity and purity.
Top Quality Cells and Methods
Accellta offers a variety of NIH-registered highly characterized ES and iPS cell lines. In addition, we offer protocols for feeder-free, xeno-free culturing.
The Power of Partnering
Accellta is looking for strategic partnerships with the goal of leveraging its technology for custom-made industrial and clinical requirements.